<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>With the aim of accurately assessing the effects of radiation exposure in the Japanese atomic-bomb survivors, the Radiation Effects Research Foundation has, over several decades, conducted studies of the Life Span Study (LSS) cohort, comprising 93 000 atomic-bomb survivors and 27 000 controls </plain></SENT>
<SENT sid="1" pm="."><plain>Solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>: the recent report on solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> incidence found that at age 70 years following exposure at age 30 years, solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> rates increase by about 35%  Gy(-1) for men and 58% Gy(-1) for women </plain></SENT>
<SENT sid="2" pm="."><plain>Age-at-exposure is an important risk modifier </plain></SENT>
<SENT sid="3" pm="."><plain>In the case of <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e>, cigarette smoking has been found to be an important risk modifier </plain></SENT>
<SENT sid="4" pm="."><plain>Radiation has similar effects on first-primary and <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">second-primary cancer</z:e> risks </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, radiation-associated increases in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> rates appear to persist throughout life </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_336'>Leukaemia</z:mpath>: the recent report on <z:mpath ids='MPATH_336'>leukaemia</z:mpath> mortality suggests that radiation effects on <z:mpath ids='MPATH_336'>leukaemia</z:mpath> mortality persisted for more than 50 years </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, significant dose-response for <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> was observed in Nagasaki LSS members even 40-60 years after radiation exposure </plain></SENT>
<SENT sid="8" pm="."><plain>Future perspective: given the continuing solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> increase in the survivor population, the LSS will likely continue to provide important new information on radiation exposure and solid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risks for another 15-20 years, especially for those exposed at a young age </plain></SENT>
</text></document>